Tag: Atrial Fibrillation
Cardiorespiratory Fitness Linked to Outcomes After A-Fib Ablation
Arrhythmia recurrence rate, mortality significantly lower in those with higher cardiorespiratory fitness
Osteoporotic Fracture Risk Lower for DOAC Than Warfarin in A-Fib
No differences seen in fracture risk in head-to-head comparisons of direct oral anticoagulants
Intensive Blood Pressure Control Tied to Lower Atrial Fibrillation Risk
Lowering systolic BP to <120 mm Hg lowers risk by 26 percent
Dual Therapy Linked to Lower Bleeding Risk in A-Fib After PCI
Low-certainty evidence showed inconclusive effects for all-cause mortality, cardiovascular mortality, MI
Apixaban Seems Safer Than Rivaroxaban for A-Fib
Lower rates seen for ischemic stroke or systemic embolism, GI bleeding or intracranial hemorrhage
Racial/Ethnic Disparity Seen for Stroke in Dialysis Patients With A-Fib
Rates of stroke higher for minority dialysis patients with a-fib partly due to lower anticoagulant use
GI Bleeding in OAC-Treated A-Fib Patients Indicates CRC Risk
Lower-GI bleeding tied to high absolute risks for CRC in patients receiving oral anticoagulants for a-fib
Electrical Cardioversion Effective for Acute A-Fib in Emergency Setting
Both drug-shock, shock-only strategies highly effective; no difference seen for pad positions
Vital Exhaustion Linked to Increased Risk for Incident A-Fib
After adjustment for comorbidities, risk remained significantly increased with vital exhaustion
Major Cardiovascular Diseases May Up Long-Term Risk for ESKD
Risk highest for heart failure; risk for heart failure nominally higher with preserved ejection fraction
